Excluding prior year self-insurance adjustments, organic growth, adjusted EPS and adjusted EBITDA exceed management expectationsFourth quarter revenue was a record $2.3 billion, an increase of 5.4% ...
Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that Mick Hitchcock, Ph.D., Interim Chief Executive Officer and Board Member, will present ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback